DERM - Journey Medical Corp
6.5
-0.370 -5.692%
Share volume: 132,387
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$6.87
-0.37
-0.05%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-22-2023 | 08-10-2023 | 11-13-2023 | 03-29-2024 | 05-14-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | |
| Total revenue | 12.213 M | 17.172 M | 34.539 M | 15.257 M | 13.030 M | 14.855 M | 14.629 M | 13.620 M | |
| Cost of revenue | 6.449 M | 7.767 M | 6.429 M | 6.015 M | 6.816 M | 6.541 M | 5.285 M | 2.237 M | |
| Gross profit | 5.764 M | 9.405 M | 28.110 M | 9.242 M | 6.214 M | 8.314 M | 9.344 M | 11.383 M | |
| 63.17% | 198.88% | -67.12% | -32.76% | 33.79% | 12.39% | 21.82% | |||
| Operating expenses | 15.325 M | 13.915 M | 10.865 M | 11.346 M | 16.304 M | 11.241 M | 12.238 M | 10.278 M | |
| Selling general and admin | 13.292 M | 12.141 M | 8.636 M | 9.841 M | 8.420 M | 10.328 M | 11.396 M | 10.060 M | |
| Research and development | 2.033 M | 1.774 M | 2.229 M | 1.505 M | 7.884 M | 913.000 K | 842.000 K | 218.000 K | |
| Total expenses | 21.774 M | 21.682 M | 17.294 M | 17.361 M | 16.304 M | 11.241 M | 12.238 M | 9.149 M | |
| -0.42% | -20.24% | 0.39% | -6.09% | -31.05% | 8.87% | -25.24% | |||
| Operating income | -9.561 M | -4.510 M | 17.245 M | -2.104 M | -10.090 M | -2.927 M | -2.894 M | 2.234 M | |
| Ebit | -9.561 M | -4.510 M | 17.245 M | -2.104 M | -10.111 M | -2.959 M | -2.945 M | 2.222 M | |
| Pretax income | -10.136 M | -8.363 M | 16.884 M | -2.017 M | -10.442 M | -3.361 M | -2.390 M | 1.582 M | |
| -17.49% | -301.89% | -111.95% | 417.70% | -67.81% | -28.89% | -166.19% | |||
| Income tax | 0.000 | 0.000 | 95.000 K | 126.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -10.136 M | -8.363 M | 16.789 M | -2.143 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| 17.49% | 300.75% | -112.76% | 100.00% | ||||||
| Net income | -10.136 M | -8.363 M | 16.789 M | -2.143 M | -10.442 M | -3.361 M | -2.390 M | 1.521 M | |
| 17.49% | 300.75% | -112.76% | -387.26% | 67.81% | 28.89% | 163.64% |
